The HA-CD44/RHAMM signaling pathway is an attractive target for cancer prevention and therapy as it regulates critical steps in tumor growth and progression, including cell proliferation, survival, migration, invasion, and the proliferation and self-renewal of cancer stem cells. This evidence concerns the gene CD44 and neoplasm.